[HTML][HTML] Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer
…, J Mo, J Dai, C Ye, W Cen, X Zheng, L Jiang, L Ye - Cell death & …, 2021 - nature.com
Cetuximab is approved for the treatment of metastatic colorectal cancer (mCRC) with RAS
wild-type. Nevertheless, the prognosis remains poor and the effectiveness of cetuximab is …
wild-type. Nevertheless, the prognosis remains poor and the effectiveness of cetuximab is …
Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases
…, X Bo, L Li, P Xiangou, L Haohao, Y Lechi… - Annals of surgical …, 2012 - Springer
Objective This study was designed to evaluate the long-time outcome of patients with
colorectal liver metastasis (CRLM) undergoing different types of therapy and identify prognosis …
colorectal liver metastasis (CRLM) undergoing different types of therapy and identify prognosis …
[HTML][HTML] Timing of hepatectomy for resectable synchronous colorectal liver metastases: for whom simultaneous resection is more suitable-a meta-analysis
Q Feng, Y Wei, D Zhu, L Ye, Q Lin, W Li, X Qin, M Lyu… - PloS one, 2014 - journals.plos.org
Background The optimal timing of resection for synchronous colorectal liver metastases is still
controversial. Retrospective cohort studies always had baseline imbalances in comparing …
controversial. Retrospective cohort studies always had baseline imbalances in comparing …
Circular RNA hsa_circRNA_102958 promotes tumorigenesis of colorectal cancer via miR-585/CDC25B axis
R Li, BB Wu, J Xia, L Ye, X Yang - Cancer management and …, 2019 - Taylor & Francis
… Lechi Ye3 Department of Colorectal and Anal Surgery, The First Affiliated Hospital of … Fang
G, Ye BL, Hu BR, Ruan XJ, Shi YX. CircRNA_100290 promotes colorectal cancer progression …
G, Ye BL, Hu BR, Ruan XJ, Shi YX. CircRNA_100290 promotes colorectal cancer progression …
[HTML][HTML] Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
D Zhu, Y Zhong, Y Wei, L Ye, Q Lin, L Ren, Q Ye, T Liu… - PloS one, 2014 - journals.plos.org
Background Whether patients with resectable colorectal liver metastases (CRLM) receive
survival benefit from neoadjuvant chemotherapy remains controversial. Methods We …
survival benefit from neoadjuvant chemotherapy remains controversial. Methods We …
Activation of autophagy through calcium‐dependent AMPK/mTOR and PKC θ pathway causes activation of rat hepatic stellate cells under hypoxic stress
Y Jin, Y Bai, H Ni, L Qiang, L Ye, Y Shan, M Zhou - FEBS letters, 2016 - Wiley Online Library
The activation of hepatic stellate cells ( HSC s) is a prominent event in liver fibrogenesis.
However, how HSC s are activated in the hypoxic microenvironment remains unclear. Here, we …
However, how HSC s are activated in the hypoxic microenvironment remains unclear. Here, we …
Comparison of minimally invasive and open colorectal resections for patients undergoing simultaneous R0 resection for liver metastases: a propensity score analysis
Q Lin, Q Ye, D Zhu, Y Wei, L Ren, P Zheng… - International journal of …, 2015 - Springer
Purpose The role of minimally invasive colorectal resection for patients undergoing a
simultaneous resection for synchronous liver metastases had not been established. This study …
simultaneous resection for synchronous liver metastases had not been established. This study …
[HTML][HTML] Deep radiomics-based fusion model for prediction of bevacizumab treatment response and outcome in patients with colorectal cancer liver metastases: A …
S Zhou, D Sun, W Mao, Y Liu, W Cen, L Ye… - …, 2023 - thelancet.com
Background Accurate tumour response prediction to targeted therapy allows for personalised
conversion therapy for patients with unresectable colorectal cancer liver metastases (…
conversion therapy for patients with unresectable colorectal cancer liver metastases (…
[HTML][HTML] Nuclear translocation of thioredoxin-1 promotes colorectal cancer development via modulation of the IL-6/STAT3 signaling axis through interaction with …
A Wu, D Fang, Y Liu, X Shi, Z Zhong, B Zhou, L Ye… - Theranostics, 2023 - ncbi.nlm.nih.gov
Background: Thioredoxin 1 (Trx-1) is a small redox protein predominantly localized in the
cytoplasm. Its expression is increased in several cancers, including colorectal cancer (CRC). …
cytoplasm. Its expression is increased in several cancers, including colorectal cancer (CRC). …
[HTML][HTML] Determinants of long-term outcome in patients undergoing simultaneous resection of synchronous colorectal liver metastases
Q Lin, Q Ye, D Zhu, Y Wei, L Ren, L Ye, Q Feng, P Xu… - PLoS …, 2014 - journals.plos.org
Background It remains unclear which patients can benefit from simultaneous resection of
synchronous colorectal liver metastases (SCRLMs). This study aimed to examine the …
synchronous colorectal liver metastases (SCRLMs). This study aimed to examine the …